The EB Medical and Scientific Advisory Panel (MSAP)
The Medical and Scientific Advisory Panel (MSAP) was created by DEBRA International more than 30 years ago. Its members are senior EB researchers and clinicians who jointly reflect the breadth of EB research.This panel works to act as guardian of scientific quality and relevance to people with EB of the research that EB Resnet funds. Research funded by EB Resnet members is mainly reviewed by this expert panel which is central to maintaining our reputation as a research funder among the academic and clinical research community, bioindustry, and research sponsors and donors. As this panel is focussing on assessing EB research ideas EB Resnet renamed it to EB MSAP.
The EB MSAP has an advisory role in relation to EB Resnet member organisations which support research, but has no executive role in any of EB Resnet's member organisations. All members of the Expert Panel work according to EB Resnet's terms of reference.
Whenever a 'special' call is launched for research proposals in a specific area of clinical or research need, or in case of for proposals requiring more extensive or alternative evaluation, additional people with the required specialist knowledge relevant to that call may be invited to join an Ad-hoc Expert Panel.
Current members
-
Prof. Thomas Magin (University of Leipzig, Germany), Co-Chair
- Prof. John Marshall (Queen Mary University London, UK), Co-Chair
- Prof. Jo-David Fine (Emeritus Professor Vanderbilt University, USA), Deputy Chair
- Prof. Cristina Has (University of Freiburg, Germany)
- Prof. Adrian Heagerty (University Hospitals Birmingham, UK)
- Prof. Veli-Matti Kähäri (University of Turku, Finland)
- Prof. Fernando Larcher (CIEMAT-CIBERER, Madrid, Spain)
- Prof. Fulvio Mavilio (University of Modena and Reggio Emilia, Italy)
- Prof. Jemma Mellerio (St John's Institute of Dermatology, London, UK)
- Prof. Guerrino Meneguzzi (ADSM - Association for the Development of Medical Sciences, Faculté de Médecine, Nice, France)
- Prof. Carien Niessen (University of Cologne, Germany)
- Dr. Agnes Schwieger-Briel (Universitäts Kinderspital Zürich, Schwitzerland)
- Prof. Andrew South (Thomas Jefferson University, USA)
- Prof. Eli Sprecher (Tel Aviv Sourasky Medical Center, Israel)
- Prof. Giovanna Zambruno (Bambino Gesù Children’s Hospital, Italy)
- Dr. Rainer Riedl (Patient Representative, Austria)
- Melanie Isele (Patient Representative, Austria)